Enliven Therapeutics, Inc. (ELVN) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.83 | +3.2% |
| 2024 | $-1.89 | +6.0% |
| 2023 | $-2.01 | +83.3% |
| 2022 | $-12.05 | -408.4% |
| 2021 | $-2.37 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.83 | +3.2% |
| 2024 | $-1.89 | +6.0% |
| 2023 | $-2.01 | +83.3% |
| 2022 | $-12.05 | -408.4% |
| 2021 | $-2.37 | — |